|Articles|May 15, 2023
Accelerated Delivery to a Development Candidate Enabled by RapidFire Mass Spectrometry
Author(s)Agilent Technologies
Time to results can be significantly reduced with the use of RapidFire high-throughput mass spectrometry (MS). With this technique, a lab’s next great innovation can be brought from conception to reality in a timely and efficient manner.
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Related Content
Trending on BioPharm International
1
Biologics, Obesity, China Top Financial Trends Reshaping Pharma R&D in J.P. Morgan Report
2
Why Product-Specific Strategies Matter in Advanced Therapy Manufacturing (Part 3)
3
Everything to Know About Cell and Gene Therapy in 2025
4
Biotech Equipment Market to Approach $144B by 2030: Implications for Pharma R&D
5
